Progyny, Inc. to Present at the 39th Annual JP Morgan Healthcare Conference
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...
Day: January 5, 2021
Adverum Biotechnologies to Present at 39th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...
Exergen Provides Critical Protective Equipment to School of Nursing Students
Protecting Those Who Protect UsWATERTOWN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Northeastern University’s School of Nursing, part of the...
Cannabinoid Non-Profit ECHO Connection Appoints Brian Higuera as New Company President and Chairman of the Board of Directors
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ECHO Connection (the “Company”), a non-profit charitable organization dedicated to...
Genenta to Take Part in Gene Therapy Panel and Two Virtual Investor Events in January 2021
MILAN, Italy and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development...
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Medigene to Take Part in Cell Therapy Panel at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
MARTINSRIED, Germany and MUNICH, Germany, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Medigene AG (FSE: MDG1, Prime Standard), a clinical stage...
Nxt-ID, Inc. Regains Compliance With Nasdaq Minimum Bid Price Requirement
Bid Price of Listed Securities Exceeds $1 at Closing for Eleven Consecutive Trading Days Oxford, Connecticut, Jan. 05, 2021 (GLOBE...
Ultragenyx to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
NOVATO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line
Clinical Strength ProCBD™ is Supported by Clinical Research and Available Exclusively Through Health Practitioners CV Sciences, Inc. Announces Launch of...
Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
OrthoPediatrics Corp. Launches Sterile Implants for PNP|FEMUR System
WARSAW, Indiana, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the...
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
BOSTON, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel...
Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing...
Predictive Oncology Hires Investor Relations Firm
MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
Fortress Biotech to Participate in Three January 2021 Virtual Investor Conferences
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on...
New Data Published in Gastroenterology Demonstrate the Power of Fluidigm’s Imaging Mass Cytometry on the Hyperion Imaging System to Identify Novel Targets for Pancreatic Cancer Therapy
Study Highlighting IMC Application in Both Protein and RNA Detection Conducted by Researchers at Fluidigm Center of Excellence for Imaging Mass...
Mustang Bio to Participate in Three January 2021 Virtual Investor Conferences
WORCESTER, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Emerald Bioscience to Present at the KCSA Cannabis Investor Conference
San Diego, Calif, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a biopharmaceutical...
Genesis HealthCare Announces Leadership Change
George V. Hager, Jr. Retires as CEO and DirectorBoard of Directors Appoints Current Chairman, Robert H. Fish as New CEO...